Last update 08 May 2025

Hangzhou Zhicheng Technology Co., Ltd.

Private Company|2022|Zhejiang Sheng, China

Overview

Tags

Nervous System Diseases
Other Diseases
Small molecule drug

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Disease DomainCount
Nervous System Diseases1
Top 5 Drug TypeCount
Small molecule drug1
Top 5 TargetCount
5-HT1A receptor x 5-HT2A receptor x D2 receptor1

Related

1
Drugs associated with Hangzhou Zhicheng Technology Co., Ltd.
Brexpiprazole
Target
5-HT1A receptor x 5-HT2A receptor x D2 receptor
Mechanism
5-HT1A receptor agonists [+2]
Active Org.
Jiangsu Hechen Pharmaceutical Co., Ltd. [+29]
Originator Org.
Otsuka Pharmaceutical Co., Ltd.Otsuka Pharmaceutical Co., Ltd.
Active Indication
Depressive Disorder [+10]
Inactive Indication
Anxiety Disorders [+11]
Drug Highest PhaseApproved
First Approval Ctry. / Loc.
United States
First Approval Date10 Jul 2015
4
Clinical Trials associated with Hangzhou Zhicheng Technology Co., Ltd.
CTR20223349
/ Not yet recruitingNot Applicable
盐酸贝尼地平片随机、开放、单剂量、两制剂、交叉设计在中国健康受试者中的药代动力学试验
[Translation] A randomized, open-label, single-dose, two-formulation, crossover pharmacokinetic study of benidipine hydrochloride tablets in healthy Chinese subjects
CTR20240814
/ CompletedNot Applicable
随机、开放、单剂量、两制剂、两序列、两周期、自身交叉对照设计，评价中国健康受试者在空腹及餐后状态下单次口服氨甲环酸片后的生物等效性正式试验
[Translation] A randomized, open-label, single-dose, two-formulation, two-sequence, two-period, self-crossover controlled study to evaluate the bioequivalence of tranexamic acid tablets in Chinese healthy subjects after a single oral dose in the fasting and fed state
CTR20231498
/ CompletedNot Applicable
吲哚布芬片随机、开放、交叉设计在中国健康受试者中的生物等效性正式试验
[Translation] A randomized, open-label, crossover design formal bioequivalence trial of indobufen tablets in Chinese healthy subjects
100 Clinical Results associated with Hangzhou Zhicheng Technology Co., Ltd.
Login to view more data
0 Patents (Medical) associated with Hangzhou Zhicheng Technology Co., Ltd.
Login to view more data
100 Deals associated with Hangzhou Zhicheng Technology Co., Ltd.
Login to view more data
100 Translational Medicine associated with Hangzhou Zhicheng Technology Co., Ltd.
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 17 May 2025

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Other
1
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
Brexpiprazole
 ( 5-HT1A receptor x 5-HT2A receptor x D2 receptor )		Depressive Disorder
More
Clinical
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free